BRIEF-Novo Nordisk Q3 Adjusted EBIT At DKK 31,720 Million, Above Estimates

Novo Nordisk A/S: * Q3 ADJUSTED REVENUE DKK 79,195 MILLION * Q3 ADJUSTED EBIT DKK 31,720 MILLION * OUTLOOK FY ADJUSTED EBIT GROWTH -2 TO 2% * OUTLOOK FY ADJUSTED REVENUE GROWTH -2 TO 2% * ADJUSTED

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)